# DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE
> **ANDA208518** · Abbreviated New Drug Application (Generic) · Sponsor: PH HEALTH · Approved 2017-12-06
## Drug
- **FDA Application Number:** ANDA208518
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE
- **Generic name:** DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE, DELAYED RELEASE TABLETS 10 MG/10 MG
- **Active ingredients:** DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE
- **Dosage form:** TABLET, DELAYED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PH HEALTH
- **Manufacturer:** Endo USA, Inc.
- **First approval:** 2017-12-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208518)
---
*MORVS · CC0 1.0*